SP Group (SPG) Q3 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2023 earnings summary
9 Nov, 2026Executive summary
9M 2023 revenue declined 2.7% to DKK 1,953.2m; EBITDA fell 8.6% to DKK 323.9m and EBT fell 35.4% to DKK 131.0m. FY guidance was maintained.
Customer inventory adjustments, higher interest rates and weaker macroeconomic activity weighed on sales and earnings; growth in coming quarters is expected from customer projects in development.
Financial highlights
9M revenue was DKK 1,953.2m vs DKK 2,007.5m; Q3 revenue was DKK 583.0m vs DKK 607.1m.
9M EBITDA was DKK 323.9m vs DKK 354.4m; EBIT was DKK 171.9m vs DKK 220.7m. Q3 EBITDA declined DKK 11.0m, or 10.5% YoY.
9M EBT was DKK 131.0m vs DKK 202.9m; net income was DKK 102.3m vs DKK 160.1m and diluted EPS was DKK 8.38 vs DKK 13.12.
Operating cash flow rose to DKK 288.6m from DKK 210.2m; investing cash outflow was DKK 120.2m vs DKK 198.6m.
Outlook and guidance
FY 2023 guidance maintained: revenue growth of 0–10%, EBITDA margin of 16–19% and EBT margin of 7–10%.
New solutions for healthcare, cleantech and food-related industries are expected to support growth; renewed wind-industry growth is anticipated in coming years.
Investment levels are expected to remain high in 2023, with healthcare the largest planned investment area; depreciation and financial expenses are expected above 2022 levels.
Latest events from SP Group
- Guidance held despite softer Q1 demand and heightened macroeconomic uncertainty.SPG
Q2 2023 - Lower 2023 earnings, stronger operating cash flow, and cautious growth guidance for 2024.SPG
Q4 2023 - Q1 earnings and margins rose; FY guidance held despite uncertainty.SPG
Q1 2024 - Own-brand growth lifted H1 earnings and supported higher FY2024 guidance amid uncertainty.SPG
Q2 2024 - Own-brand growth lifted 9M EBITDA 38.1%; FY revenue growth guidance is 10–16%.SPG
Q3 2024 - Record revenue and margin growth in 2024, with strong outlook for 2025.SPG
Q4 2024 - H1 2025 saw lower sales and earnings, but margins and full-year outlook remain stable.SPG
Q2 2025 - Own-brand growth lifted 9M earnings as FY revenue guidance narrowed to 10%-16%.SPG
Q3 2024 - Q1 2025 saw 8.8% revenue growth, strong margins, and robust Healthcare segment gains.SPG
Q1 2025